Home/Filings/4/0001415889-25-006035
4//SEC Filing

Horan Christopher 4

Accession 0001415889-25-006035

CIK 0001817241other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:15 PM ET

Size

4.8 KB

Accession

0001415889-25-006035

Insider Transaction Report

Form 4
Period: 2025-02-26
Horan Christopher
Chief Tech Operations Officer
Transactions
  • Award

    Common Stock

    2025-02-26+60,00085,000 total
Footnotes (1)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.

Issuer

Artiva Biotherapeutics, Inc.

CIK 0001817241

Entity typeother

Related Parties

1
  • filerCIK 0001736819

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:15 PM ET
Size
4.8 KB